Provectus Biopharmaceuticals, Inc. (PVCT)

USD 0.1

(-3.01%)

Revenue Summary of Provectus Biopharmaceuticals, Inc.

  • Provectus Biopharmaceuticals, Inc.'s latest annual revenue in 2023 was 557.71 Thousand USD , down -43.61% from previous year.
  • Provectus Biopharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q2 was 254.99 Thousand USD , up 7.11% from previous quarter.
  • Provectus Biopharmaceuticals, Inc. reported a annual revenue of 989.04 Thousand USD in annual revenue 2022, down 0.0% from previous year.
  • Provectus Biopharmaceuticals, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Provectus Biopharmaceuticals, Inc. reported a quarterly revenue of 238.07 Thousand USD for 2024 Q1, up 96.58% from previous quarter.
  • Provectus Biopharmaceuticals, Inc. reported a quarterly revenue of 121.11 Thousand USD for 2023 Q4, up 73.68% from previous quarter.

Annual Revenue Chart of Provectus Biopharmaceuticals, Inc. (2023 - 2000)

Historical Annual Revenue of Provectus Biopharmaceuticals, Inc. (2023 - 2000)

Year Revenue Revenue Growth
2023 557.71 Thousand USD -43.61%
2022 989.04 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 4.17 Million USD 0.0%
2013 - USD 0.0%
2012 - USD -100.0%
2011 9.75 Billion USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD -100.0%
2006 1368.00 USD -79.07%
2005 6536.00 USD -79.48%
2004 31.85 Thousand USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 1.00 USD 0.0%

Peer Revenue Comparison of Provectus Biopharmaceuticals, Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -636.504%
Evofem Biosciences, Inc. 18.21 Million USD 96.939%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.546%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 71.133%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 96.464%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -3065.03%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 97.403%
Intellipharmaceutics International Inc. 65.72 Thousand USD -748.512%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 90.55%
Marizyme, Inc. 645.81 Thousand USD 13.642%
Genus plc 668.8 Million USD 99.917%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.773%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -463.378%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -35.972%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -626.554%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1311.281%
MultiCell Technologies, Inc. 49.32 USD -1130698.865%
ONE Bio Corp. 52.29 Million USD 98.934%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 98.878%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -1040.511%
Q BioMed Inc. 284.35 Thousand USD -96.134%
Emmaus Life Sciences, Inc. 29.59 Million USD 98.116%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.616%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -696.729%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 15.306%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.996%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -55726.827%
Enzolytics Inc. 52.79 Thousand USD -956.349%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 8.351%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.955%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -297.677%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 9.666%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.934%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 44.102%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 98.847%
BioStem Technologies, Inc. 16.68 Million USD 96.657%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -135.758%
Regen BioPharma, Inc. 236.56 Thousand USD -135.758%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 59.262%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -17.727%
SYBLEU INC 11.69 Thousand USD -4668.382%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 92.84%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -4190.077%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1310.71%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 83.252%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 91.632%
IntelGenx Technologies Corp. 1.03 Million USD 46.322%
Gelesis Holdings, Inc. 25.76 Million USD 97.836%
CSL Limited 14.8 Billion USD 99.996%
Cellectis S.A. 755 Thousand USD 26.131%